454 filings
8-K
VNDA
Vanda Pharmaceuticals Inc
7 Mar 24
Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZĀ® in the Treatment of Insomnia
4:31pm
8-K
VNDA
Vanda Pharmaceuticals Inc
21 Feb 24
Departure of Directors or Certain Officers
4:32pm
8-K/A
VNDA
Vanda Pharmaceuticals Inc
16 Feb 24
Special Purpose Abbreviated Financial Statements
4:31pm
10-K
2023 FY
VNDA
Vanda Pharmaceuticals Inc
Annual report
8 Feb 24
7:19am
8-K
VNDA
Vanda Pharmaceuticals Inc
7 Feb 24
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
4:07pm
8-K
1ih5xgrck7w b58
5 Feb 24
Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZĀ® in the Treatment of Insomnia
4:34pm
8-K
hdu2 pkh8
15 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:15pm
8-K
pvrhuvnwq8c0ee7
7 Dec 23
Entry into a Material Definitive Agreement
5:19pm
8-K
1h536ra
8 Nov 23
Vanda Pharmaceuticals Reports Third Quarter 2023 Financial Results
4:05pm
8-K
1sml72o2
21 Aug 23
Other Events
5:13pm
8-K
vcg57k fydatas
27 Jul 23
Vanda Pharmaceuticals Reports Second Quarter 2023 Financial Results
4:06pm
S-8
euikbg 7mu
8 Jun 23
Registration of securities for employees
4:46pm
8-K
67vl0a q5na
8 Jun 23
Submission of Matters to a Vote of Security Holders
4:40pm
8-K
lws22t7leea 94sojd6v
11 May 23
Other Events
7:01am
EFFECT
uadgq rmgbdixqpr3
8 May 23
Notice of effectiveness
12:15am
S-3/A
o7jww6vgbutdgkd1l
3 May 23
Shelf registration (amended)
5:10pm
8-K
dei8 7jlgb
3 May 23
Vanda Pharmaceuticals Reports First Quarter 2023 Financial Results
4:05pm